Additionally, genetic or pharmacological inhibition of NOX4 has been shown to exert protective effects against S-AKI through reducing ROS generation and NF-κB activation, thereby alleviating mitochondrial dysfunction, inflammation, and apoptosis [29]. The gene discussed is NFKB1; the disease is acute kidney injury.